Targeting activated integrin αvβ3 with patient-derived antibodies impacts late-stage multiorgan metastasis

Karin Staflin, Brunhilde Felding‐Habermann(Scripps Research Institute), Kim D. Janda(Scripps Research Institute), Cristina Pop(Iuliu Hațieganu University of Medicine and Pharmacy), Jenny M. Mee(Scripps Research Institute), Mihaela Lorger(University of Leeds), Joseph S. Krueger(Scripps Research Institute), Jane Forsyth, Sebastian C.J. Steiniger(Scripps Research Institute), Guy S. Salvesen(Discovery Institute), Janna Hachmann(Scripps Research Institute)
Clinical & Experimental Metastasis
March 12, 2010
Cited by 13


Related Papers

Contribution of platelets to tumour metastasis
|Nature reviews. Cancer|2011|1.6k
Lysosomal Protease Pathways to Apoptosis
|Journal of Biological Chemistry|2001|658
Integrin activation controls metastasis in human breast cancer
|Proceedings of the National Academy of Sciences|2001|580
Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
|Proceedings of the National Academy of Sciences|2012|580